EUVIMEDEUVIMED entdecken
Crossref

Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C 44 Mab-108) Using Enzyme-Linked Immunosorbent Assay

Hiroyuki Suzuki, Mayuki Tawara, Aoi Hirayama, Nohara Goto, Tomohiro Tanaka, Mika K Kaneko, Yukinari Kato iD

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy · 2024

DOI: 10.1089/mab.2023.0022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, 2024. Verfasst von Hiroyuki Suzuki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Antibodies, Monoclonal, Epitope Mapping, Enzyme-Linked Immunosorbent Assay. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CD44 is a type I transmembrane glycoprotein and possesses various isoforms which are largely classified into CD44 standard (CD44s) and CD44 variant (CD44v) isoforms. Some variant-encoded regions play critical roles in tumor progression. However, the function of CD44 variant 4 (CD44v4)-encoded region has not been fully understood. Using peptide immunization, we developed an anti-CD44v4 monoclonal antibody, C44Mab-108, which is useful for flow cytometry, western blotting, and immunohistochemistry. In this study, we determined the critical epitope of C44Mab-108 by enzyme-linked immunosorbent assay (ELISA). We used the alanine (or glycine)-substituted peptides of the CD44v4-encoded region (amino acids 271-290 of human CD44v3-10) and found that C44Mab-108 did not recognize the alanine-substituted peptides of D280A and W281A. Furthermore, these peptides could not inhibit the recognition of C44Mab-108 in flow cytometry and immunohistochemistry. The results indicate that the critical binding epitope of C44Mab-108 includes Asp280 and Trp281 of CD44v3-10.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyaluronan ReceptorsAntibodies, MonoclonalEpitope MappingEnzyme-Linked Immunosorbent AssayFlow CytometryHumansAnimalsEpitopesImmunohistochemistryMiceProtein IsoformsPeptides

Stichwörter der Autor:innen

CD44CD44 variant 4enzyme-linked immunosorbent assayepitopemonoclonal antibody

Substanzen

Hyaluronan ReceptorsAntibodies, MonoclonalCD44 protein, humanEpitopesProtein IsoformsPeptides

Autor:innen und Institutionen

  • Department of Antibody Drug Development, Tohoku University Graduate School of Medicine, Sendai, Japan.

ORCID-Profile: Yukinari Kato

Zitieren

APA

Suzuki, H., Tawara, M., Hirayama, A., Goto, N., Tanaka, T., Kaneko, M. K., & Kato, Y. (2024). Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C 44 Mab-108) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. https://doi.org/10.1089/mab.2023.0022

Vancouver

Suzuki H, Tawara M, Hirayama A, Goto N, Tanaka T, Kaneko MK, et al. Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C 44 Mab-108) Using Enzyme-Linked Immunosorbent Assay. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 2024. doi:10.1089/mab.2023.0022

BibTeX
@article{Suzuki2024,
  author = {Suzuki, Hiroyuki and Tawara, Mayuki and Hirayama, Aoi and Goto, Nohara and Tanaka, Tomohiro and Kaneko, Mika K and Kato, Yukinari},
  title = {Epitope Mapping of an Anti-CD44v4 Monoclonal Antibody (C 44 Mab-108) Using Enzyme-Linked Immunosorbent Assay},
  journal = {Monoclonal Antibodies in Immunodiagnosis and Immunotherapy},
  year = {2024},
  doi = {10.1089/mab.2023.0022}
}
Kostenlos starten →